ClinicalTrials.Veeva

Menu

Effect of CFR and Iron Supplementation on Iron Status and Gut Microbiota of 1-2 Years Old Myanmar Children

S

SEAMEO Regional Centre for Food and Nutrition

Status and phase

Unknown
Phase 3

Conditions

Iron Deficiency Anemia
Iron Deficiency

Treatments

Dietary Supplement: Iron supplementation
Other: CFR

Study type

Interventional

Funder types

Other

Identifiers

NCT01758159
HHlaing CFR Myanmar

Details and patient eligibility

About

Complementary feeding diet in developing countries cannot meet iron requirements of infants and young children. Iron supplementation is mostly used to treat iron deficiency whereas iron fortification is cost-effective strategy to control iron deficiency in developing countries. However, a recent study showed that iron fortification imposed negative impact on gut microbiota by increasing colonization of gut pathogen over beneficial bacteria. Gut microbiota plays essential roles in nutrient absorption, vitamin synthesis; intestinal mucosal barrier function and pathogen displacement. Iron is essential for growth and virulence of most gut pathogens and so iron supplementation might have similar negative impact on gut microbiota composition. Therefore, nutrition interventions would not be justified by assessing micronutrient status alone ignoring any possible deterioration of gut microbiota. The investigators hypothesized that optimizing the nutrient intake from locally available foods according to complementary feeding recommendation (CFR) can improve the iron status of these children while maintaining healthy gut microbiota composition.

A randomized, placebo-controlled, community-based, intervention trial will be conducted in Ayeyarwady division of Myanmar where childhood undernutrition is prevalent. The aim of this study is to compare the effect of optimized CFR to iron supplementation on iron status and gut microbiota composition of 1-2years old Myanmar children. Cluster randomization will be done at the village level to randomly allocate the villages into CFR or non-CFR villages. Individual randomization will be done to randomly assign each child into iron or placebo syrup so that individual children will receive one of 4 treatment groups (CFR, Fe, CFR + Fe, and Control) for a period of 24 weeks. Based on expected between-groups difference of hemoglobin 5g/L, at 80% power, 5% level of significance, 15% drop-out rate; after taking into account the cluster effect; required sample will be 109 per group (total = 436). A sub-sample of 15 children from each group will be randomly selected for gut microbiota assessment (total = 60). Blood samples for iron status and stool samples for gut microbiota assessment will be collected at baseline and endline. Anthropometric measurements, usual intake of iron and infectious disease morbidity will also be assessed.

Enrollment

433 patients

Sex

All

Ages

12 to 18 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age between 12-18 months
  • Apparently healthy
  • Not consuming regular iron containing supplements during the last 4 months

Exclusion criteria

  • With severe anemia (Hemoglobin < 50g/L)
  • Malaria test positive with Immuno-chromatographic test (ICT)
  • Mothers/ Caregivers are not willing to join the study
  • Suffer from chronic diseases which can affect their dietary intake

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Quadruple Blind

433 participants in 4 patient groups, including a placebo group

CFR group
Experimental group
Description:
The children in this group will receive complementary feeding with locally available foods according to optimized complementary feeding recommendation (CFR)
Treatment:
Dietary Supplement: Iron supplementation
Fe group
Experimental group
Description:
The children in this group will receive iron supplementation 2mg/kg/day of ferric Na EDTA (in the form of syrup) daily for 24 weeks duration.
Treatment:
Other: CFR
CFR + Fe group
Experimental group
Description:
The children in this group will receive both local food-based complementary feeding according to CFR and Iron supplementation for 24 weeks duration
Treatment:
Dietary Supplement: Iron supplementation
Other: CFR
Control group
Placebo Comparator group
Description:
The children in this group will receive basic health services and placebo syrup.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems